149 related articles for article (PubMed ID: 7274028)
1. New drug evaluations amiloride (Midamor, Merck, Sharp and Dohme).
Macfie HL; Colvin CL; Anderson PO
Drug Intell Clin Pharm; 1981 Feb; 15(2):94-8. PubMed ID: 7274028
[TBL] [Abstract][Full Text] [Related]
2. Maintenance of potassium balance during diuretic therapy.
Kohvakka A; Eisalo A; Manninen V
Acta Med Scand; 1979; 205(4):319-24. PubMed ID: 373393
[TBL] [Abstract][Full Text] [Related]
3. [Potassium-sparing diuretics (spironolactone, triamterene, amylorid)].
Haris A; Radó J
Orv Hetil; 1996 Sep; 137(35):1907-14. PubMed ID: 8927344
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension.
Maxwell MH; Brachfeld J; Itskovitz H; Lunn JA; Moser M; Zawada ET
Clin Pharmacol Ther; 1985 Jan; 37(1):61-5. PubMed ID: 3880686
[TBL] [Abstract][Full Text] [Related]
5. Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension.
Jeunemaitre X; Charru A; Chatellier G; Degoulet P; Julien J; Plouin PF; Corvol P; Ménard J
Am J Cardiol; 1988 Nov; 62(16):1072-7. PubMed ID: 3189169
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of potassium balance during long-term diuretic therapy in chronic heart failure patients with thiazide-induced hypokalemia: comparison of potassium supplementation with potassium chloride and potassium-sparing agents, amiloride and triamterene.
Kohvakka A
Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):273-7. PubMed ID: 3045028
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses of amiloride hydrochloride, a new potassium-sparing diuretic.
Vidt DG
Pharmacotherapy; 1981; 1(3):179-87. PubMed ID: 6927605
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion.
Zawada ET
Arch Intern Med; 1986 Jul; 146(7):1312-4. PubMed ID: 3521523
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacology of potassium-sparing diuretics: amiloride and triamterene].
Rorive G; Bovy P
Coeur Med Interne; 1978; 17(2):207-15. PubMed ID: 350481
[No Abstract] [Full Text] [Related]
10. Comparison of thiazides and amiloride in treatment of moderate hypertension.
Thomas JP; Thomson WH
Br Med J (Clin Res Ed); 1983 Jun; 286(6383):2015-8. PubMed ID: 6409208
[TBL] [Abstract][Full Text] [Related]
11. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
Ramsay LE; Hettiarachchi J; Fraser R; Morton JJ
Clin Pharmacol Ther; 1980 Apr; 27(4):533-43. PubMed ID: 7357812
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of diuretic-induced hypokalemia by amiloride, a potassium-sparing agent.
Ram CV; Holland OB; Kaplan NM
J Clin Pharmacol; 1981; 21(11):484-7. PubMed ID: 7334141
[No Abstract] [Full Text] [Related]
13. Comparison of the potassium- retaining effects of amiloride and spironolactone in hypertensive patients with thiazide-induced hypokalaemia.
George CF; Breckenridge AM; Dollery CT
Lancet; 1973 Dec; 2(7841):1288-91. PubMed ID: 4127641
[No Abstract] [Full Text] [Related]
14. Oral potassium chloride and amiloride in hydrochlorothiazide-induced potassium loss.
Maronde RF; Barr J; Vlachakis ND; Spencer CA; Chan L
Clin Pharmacol Ther; 1984 Oct; 36(4):431-5. PubMed ID: 6478730
[TBL] [Abstract][Full Text] [Related]
15. Clinical use of the potassium-sparing diuretics.
Krishna GG; Shulman MD; Narins RG
Semin Nephrol; 1988 Dec; 8(4):354-64. PubMed ID: 3068756
[No Abstract] [Full Text] [Related]
16. Potassium conservation with amiloride/hydrochlorothiazide ("Moduret') in thiazide-induced hypokalaemia in hypertension.
Fernandez PG; Sharma JN; Galway AB; Campbell N; Kim BK; Snedden W; Granter-Button S; MacDonald J; Gill V
Curr Med Res Opin; 1982; 8(2):120-7. PubMed ID: 7049587
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of the hypotensive action of monotherapy using hydrochlorothiazide and its combination with triamterene and amiloride and their effect on hemodynamics at rest and during exercise therapy].
Glezer GA; Lipko DS; Levinzon AM
Kardiologiia; 1990 Jul; 30(7):11-3. PubMed ID: 2232453
[TBL] [Abstract][Full Text] [Related]
18. Potassium-sparing diuretics: spironolactone v. triamterene and amiloride.
Drug Ther Bull; 1972 Apr; 10(8):30-2. PubMed ID: 5038791
[No Abstract] [Full Text] [Related]
19. Paradoxical reversal of the suppressed potassium secretion during treatment with combinations of antikaluretic agents (spironolactone, canrenone, triamterene, amiloride); a possible site of action in Henle's loop.
Radó JP; Sawinsky I; Juhos E
Horm Metab Res; 1976 May; 8(3):250-1. PubMed ID: 939474
[No Abstract] [Full Text] [Related]
20. Treating essential hypertension. The first choice is usually a thiazide diuretic.
Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
